Citation Impact
Citing Papers
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
2008 Standout
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
2008
Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study
2007
Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma
2008
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2011
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States
2015
Chimerism of the Transplanted Heart
2002 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
1989
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
The β-Thalassemias
1999 Standout
Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis
2007
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Microchimerism, GVHD, and tolerance in solid organ transplantation
2001
How Can We Prevent Lyme Disease?
2003
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Lyme Disease
2001
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
1993 Standout
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
1989 StandoutNobel
Multiple sclerosis
2008 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
2014 StandoutNobel
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
DNA Damage and Oxygen Radical Toxicity
1988 StandoutScience
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
2010 Standout
A Risk-Benefit Assessment of Iron-Chelation Therapy
1997
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Transcriptional control of granulocyte and monocyte development
2007
p73 is a human p53-related protein that can induce apoptosis
1997 StandoutNatureNobel
Prevention of Lyme borreliosis
2005
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update
2004
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Bone Marrow Transplantation
1994
Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter
2003
Disseminated Intravascular Coagulation
1999 Standout
Reprogramming the Immune System for Peripheral Tolerance with CD4 and CD8 Monoclonal Antibodies
1992
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Lyme borreliosis
2003
Early Lyme Disease
2006
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters
2007
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
2006 Standout
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
Extrathymic positive selection of αβ T-cell precursors in nude mice
1992 StandoutNatureNobel
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
2009
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis
2010 Standout
The window of therapeutic opportunity in multiple sclerosis
2005
Chimeric antigen receptor T-cell therapies for lymphoma
2017
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Iron-Chelating Therapy
1988
Peripheral T- cell lymphomas: diagnosis and management
2003
Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.
1984 StandoutNobel
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Altered activity of the nucleotide regulatory site in the parathyroid hormone-sensitive adenylate cyclase from the renal cortex of a patient with pseudohypoparathyroidism.
1978
Excessive Thyrotropin Response to Thyrotropin-releasing Hormone in Pseudohypoparathyroidism
1975
Bendamustine: Rebirth of an Old Drug
2009
Psychosocial Influences on Mortality after Myocardial Infarction
1984 Standout
Marrow Transplantation for Malignant Disease
1987
Heterogeneity of Parathyroid Hormone. CLINICAL AND PHYSIOLOGIC IMPLICATIONS
1973 StandoutNobel
Sustained-Release Formulation of Doxycycline Hyclate for Prophylaxis of Tick Bite Infection in a Murine Model of Lyme Borreliosis
2004
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
1990
Effect of parathyroid hormone on erythropoiesis.
1981
A Family of cAMP-Binding Proteins That Directly Activate Rap1
1998 StandoutScience
Absence of p53 gene mutations in primary neuroblastomas.
1993
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Excessive Thyrotropin Response to Thyrotropin-releasing Hormone in Pseudohypoparathyroidism
1975
Studies on the Mechanism of Hormone Action
1972 ScienceNobel
A Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin's Lymphoma
2008
Effects of Thyroid Hormones on Bone and Mineral Metabolism
1990
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
"Infectious" Transplantation Tolerance
1993 StandoutScience
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia [see comments]
1992
Chimeric Antigen Receptor Therapy
2018 Standout
Prevention of Intravascular Catheter–Related Infections
2000
Bone Marrow Transplant
1990 Standout
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
2009
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Carbohydrate metabolism and concentration profiles of solutes in the canine lumbar intervertebral disc
1982
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Heme-Containing Oxygenases
1996 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Treatment of Cooley's anemia [see comments]
1990
Chronic myelogenous leukemia: a concise update
1993
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
2010
Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis
2002
Oxygen toxicity, oxygen radicals, transition metals and disease
1984 Standout
Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation
1990
Coinfections Acquired from Ixodes Ticks
2006
Thrombotic Complications of Central Venous Catheters in Cancer Patients
2004
Minidose Warfarin Prophylaxis for Catheter-Associated Thrombosis in Cancer Patients: Can It Be Safely Associated With Fluorouracil-Based Chemotherapy?
2003
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
1987 Standout
Works of Robert Marcus being referenced
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party
2013
The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma.
1991
Graft-versus-host disease in solid organ transplantation
1991
High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study.
1991
Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies
1990
Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies
1998
Prophylaxis with Single-Dose Doxycycline for the Prevention of Lyme Disease after anIxodes scapularisTick Bite
2001
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation
2005
CAMPATH‐1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura
1993
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
1998
Chimeric Anti-CD20 Monoclonal Antibody (Rituximab; Mabtheraa) in Remission Induction and Maintenance Treatment of Relapsed /Resistant Follicular Non-Hodgkin’s Lymphoma : A Phase III Randomized Intergroup Clinical Trial.
2004
Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia
1986
The therapeutic use of rituximab in non‐Hodgkin's lymphoma
2006
Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
2008
Parathyroid Hormone-Sensitive Adenyl Cyclase from the Renal Cortex of a Patient with Pseudohypoparathyroidism
1971
The Cost-Effectiveness of Rituximab, Cyclophosphamide, Vincristine and Prednisolone (RCVP) Compared with CVP for the Treatment of Follicular Non-Hodgkin’s Lymphoma (NHL) in the UK.
2006
Graft-versus-host disease in solid organ transplantation
1991
Cyclic Nucleotide Phosphodiesterase from Bone: Characterization of the Enzyme andStudies of Inhibition by Thyroid Hormones
1975
High-Dose Therapy and Autologous Stem-Cell Transplantation for Adult Patients With Hodgkin's Disease Who Do Not Enter Remission After Induction Chemotherapy: Results in 175 Patients Reported to the European Group for Blood and Marrow Transplantation
1999
Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial
2006
OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINE
1983
MabThera (Rituximab) Plus Cyclophosphamide, Vincristine and Prednisone (CVP) Chemotherapy Improves Survival in Previously Untreated Patients with Advanced Follicular Non-Hodgkin’s Lymphoma (NHL).
2006
Chimeric Anti-CD20 Monoclonal Antibody (Rituximab;Mabthera) in Remission Induction and Maintenance Treatment of Relapsed /Resistant Follicular Non-Hodgkin’s Lymphoma: Final Analysis of a Phase III Randomized Intergroup Clinical Trial.
2005
Efficacy and Safety of Oral Fludarabine Phosphate in Previously Untreated Patients With Chronic Lymphocytic Leukemia
2004
Effect of Low Oxygen Tensions on Glucose-Metabolizing Enzymes in Cultured Articular Chondrocytes
1973
Structure, synthesis, and mechanism of action of parathyroid hormone.
1972
Adult acute lymphoblastic leukaemia: A study of prognostic features and response to treatment over a ten year period
1986
A prospective trial of young red cells in 48 patients with transfusion‐dependent thalassaemia
1985